Case report: Drug interaction between tacrolimus and amiodarone with qt prolongation

Transplantation

Volumn 89, Issue 9, 2010, Pages 1166-1167

  Burger, Cathy I ^a   Clase, Catherine M ^a   Gangji, Azim S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; AMIODARONE; BETAHISTINE; CALCIUM CARBONATE; CORTICOSTEROID; COTRIMOXAZOLE; CYTOCHROME P450 3A4; INSULIN; LANSOPRAZOLE; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; SIMVASTATIN; TACROLIMUS;

ADULT; CASE REPORT; DRUG METABOLISM; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QT PROLONGATION;

EID: 77951859419     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d2fed7     Document Type: Letter

References (10)

1. Wyeth. Cordarone (Amiodarone) product monograph 2009, Philadelphia, PA, Wyeth Pharmaceuticals Inc., 2009.
2. Astellas. Prograf (Tacrolimus) product monograph 2009, Markham, ON, Astellas Pharma Canada, Inc., 2009.
3. Nalli N, Stewart-Teixeira L, Dipchand AI. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient. Pediatr Transplant 2006; 10: 736.
4. Kisters K, Cziborra M, Funke C, et al. Amioda-rone-tacrolimus interaction in kidney transplantation. Clin Nephrol 2008; 70: 563.
5. Fauconier J, Lacampagne A, Rauzier JM, et al. Frequency-dependent and proarrhythmo-genic effects of FK-506 in rat ventricular cells. Am J Physiol Heart Circ Physiol 225; 288: H778.
6. Minematsu T, Ohtani H, Sato H, et al. Sustained QT prolongation induced by tacrolimus in guinea pigs. Life Sci 1999; 65: PL197.
7. Lim HE, Pak HN, Ahn JC, et al. Torsades de pointed induced by short-term oral amioda-rone therapy. EUROPACE 2006; 8: 1051.
8. Redfern WS, Carlsson L, Davis AS, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardio-vas Res 2003; 58: 32.
9. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to tor-sade de pointes tachycardia. Ann Intern Med 1994; 121: 529.
10. Harnett JD, Foley RN, Kent GM, et al. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884